Abstract:Stress, a common phenomenon in today’s society, is suspected of playing a role in the development of disease. Stressors of various types, psychological, physical, and biological, abound. They occur in the working and social environments, in air, soil, water, food, and medicines. Stressors impact on cells directly or indirectly, cause protein denaturation, and elicit a stress response. This is mediated by stress (heat-shock) genes and proteins, among which are those named molecular chaperones because they assist other proteins to achieve and maintain a functional shape (the native configuration), and to recover it when partially lost due to stress. Denatured proteins tend to aggregate and precipitate. The same occurs with abnormal proteins due to mutations, or to failure of post-transcriptional or post-translational mechanisms. These abnormal proteins need the help of molecular chaperones as much as denatured molecules do, especially during stress. A cell with normal antistress mechanisms, including a complete and functional set of chaperones, may be able to withstand stress if its intensity is not beyond that which will cause irreversible protein damage. There is a certain threshold that normal cells have above which they cannot cope with stress. A cell with an abnormal protein that has an intrinsic tendency to misfold and aggregate is more vulnerable to stress than normal counterparts. Furthermore, these abnormal proteins may precipitate even in the absence of stress and cause diseases named proteinopathies. It is possible that stress contributes to the pathogenesis of proteinopathies by promoting protein aggregation, even in cells that possess a normal chaperoning system. Examples of proteinopathies are age-related degenerative disorders with protein deposits in various tissues, most importantly in the brain where the deposits are associated with neuronal degeneration. It is conceivable that stress enhances the progression of these diseases by facilitating protein unfolding and misfolding, which lead to aggregation and deposition. A number of reports in the last few years have described research aimed at elucidating the role of heatshock proteins, molecular chaperones in particular, in the pathogenesis of neurodegenerative disorders. The findings begin to shed light on the molecular mechanism of protein aggregation and deposition, and of the ensuing cell death. The results also begin to elucidate the role of molecular chaperones in pathogenesis. This is a fascinating area of research with great clinical implications. Although there are already several experimental models for the study of proteinopathies, others should be developed using organisms that are better known now than only a few years ago and that offer unique advantages. Use of these systems and of information available in databases from genome sequencing efforts should boost research in this field. It should be possible in the not-too-distant future to develop therapeutic and preventive means for proteinopathies based on the use of heat-shock protein and molecular chaperone genes and proteins.

[Heat shock proteins as chaperones of the immune response. The optimal stress of life]

Heat-Shock Proteins in Neuroinflammation

Heat-shock proteins and molecular chaperones: implications for pathogenesis, diagnostics, and therapeutics

HEAT-SHOCK PROTEINS, MOLECULAR CHAPERONES, AND THE STRESS RESPONSE: Evolutionary and Ecological Physiology

Heat Shock Proteins in the Immune System

Current Understanding and Future Opportunities in Human Diseases

Stress and molecular chaperones in disease

Heat-shock proteins: new keys to the development of cytoprotective therapies

Heat shock proteins functioning as molecular chaperones: their roles in normal and stressed cells

Heat Shock Gene Inactivation and Protein Aggregation with Links to Chronic Diseases

Infections, heat shock proteins, and atherosclerosis.

The heat shock response and small molecule regulators

Heat Shock Proteins and Whole Body Physiology

Molecular chaperones and heat shock proteins in atherosclerosis

Small heat-shock proteins: important players in regulating cellular proteostasis

Heat Shock Protein 70 as a Double Agent Acting Inside and Outside the Cell: Insights into Autoimmunity

Role of heat shock proteins (molecular chaperones) in intestinal mucosal protection

Heat Shock Proteins as Immunomodulants

The Role of Extracellular Heat Shock Proteins in Cardiovascular Diseases

Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators

Heat shock protein 60 and cardiovascular diseases: An intricate love‐hate story